Association between PD start year and the PR of assisted PD initiation, adjusting for patient characteristics, for each type of assistance
Explanatory variable . | All assistance . | Nurse-assistance . | Family-assistance . |
---|---|---|---|
PR (95% CI) . | PR (95% CI) . | PR (95% CI) . | |
PD start year (reference = 2013) | PD start yeara | ||
2006 | 1.17 (1.07–1.29) | 1.08 (0.96–1.22) | 0.94 (0.92–0.97) a |
2007 | 1.27 (1.15–1.39) | 1.19 (1.05–1.34) | |
2008 | 1.24 (1.12–1.37) | 1.13 (0.99–1.27) | |
2009 | 1.21 (1.10–1.32) | 1.18 (1.05–1.33) | |
2010 | 1.14 (1.04–1.26) | 1.14 (1.02–1.28) | |
2011 | 1.09 (0.99–1.21) | 1.08 (0.96–1.21) | |
2012 | 1.16 (1.06–1.28) | 1.15 (1.03–1.27) | |
2013 | Reference | Reference | |
2014 | 1.08 (0.99–1.19) | 1.14 (1.02–1.29) | |
2015 | 1.12 (1.03–1.23) | 1.24 (1.11–1.34) | |
Age, for a 10-year increase | 1.79 (1.75–1.83) | 1.83 (1.79–1.88) | 1.19 (1.14–1.25) |
Gender, male | 0.71 (0.68–0.74) | 0.70 (0.66–0.73) | 1.06 (0.94–1.20) |
Diabetes | 1.13 (1.07–1.20) | 1.10 (1.03–1.18) | 1.21 (1.02–1.44) |
Modified CCI (per unit) | 1.09 (1.08–1.11) | 1.06 (1.05–1.08) | 1.14 (1.10–1.18) |
Suboptimal starters | 1.11 (1.04–1.19) | 1.17 (1.07–1.26) | 0.90 (0.73–1.10) |
Underlying nephropathy | |||
Polycystic kidney disease | Reference | Reference | Reference |
Diabetes | 2.30 (1.93–2.74) | 2.16 (1.77–2.63) | 1.93 (1.26–2.96) |
Interstitial nephritis | 2.16 (1.79–2.61) | 2.04 (1.65–2.51) | 2.02 (1.28–3.18) |
Glomerulonephritis | 1.36 (1.13–1.63) | 1.26 (1.02–1.55) | 1.42 (0.92–2.18) |
Unknown | 2.18 (1.83–2.59) | 2.09 (1.72–2.54) | 1.73 (1.13–2.66) |
Uropathy | 1.84 (1.48–2.29) | 1.72 (1.34–2.21) | 1.79 (1.06–2.99) |
Vascular | 2.35 (1.99–2.78) | 2.22 (1.84–2.68) | 1.91 (1.27–2.87) |
Systemic disease | 1.87 (1.47–2.38) | 1.77 (1.35–2.33) | 1.72 (0.97–3.04) |
Other | 2.23 (1.68–2.95) | 2.06 (1.50–2.82) | 2.43 (1.18–5.01) |
Therapy before PD initiation | |||
No therapy | Reference | Reference | Reference |
HD | 1.14 (1.08–1.20) | 1.04 (0.97–1.12) | 1.32 (1.13–1.54) |
Transplantation | 0.54 (0.41–0.71) | 0.54 (0.39–0.74) | 0.67 (0.39–1.15) |
Type of centre | |||
Academic hospital | Reference | Reference | Reference |
Community hospital | 1 (0.95–1.07) | 1.03 (0.96–1.11) | 0.94 (0.79–1.11) |
Non-profit | 1 (0.93–1.07) | 0.98 (0.90–1.07) | 1.08 (0.90–1.30) |
Private hospital | 0.94 (0.87–1.02) | 0.94 (0.84–1.04) | 0.99 (0.77–1.28) |
Centre experience (new patients per year) | |||
≤10 | Reference | Reference | Reference |
>10 | 1.14 (1.09–1.20) | 1.17 (1.10–1.23) | 0.99 (0.87–1.13) |
Explanatory variable . | All assistance . | Nurse-assistance . | Family-assistance . |
---|---|---|---|
PR (95% CI) . | PR (95% CI) . | PR (95% CI) . | |
PD start year (reference = 2013) | PD start yeara | ||
2006 | 1.17 (1.07–1.29) | 1.08 (0.96–1.22) | 0.94 (0.92–0.97) a |
2007 | 1.27 (1.15–1.39) | 1.19 (1.05–1.34) | |
2008 | 1.24 (1.12–1.37) | 1.13 (0.99–1.27) | |
2009 | 1.21 (1.10–1.32) | 1.18 (1.05–1.33) | |
2010 | 1.14 (1.04–1.26) | 1.14 (1.02–1.28) | |
2011 | 1.09 (0.99–1.21) | 1.08 (0.96–1.21) | |
2012 | 1.16 (1.06–1.28) | 1.15 (1.03–1.27) | |
2013 | Reference | Reference | |
2014 | 1.08 (0.99–1.19) | 1.14 (1.02–1.29) | |
2015 | 1.12 (1.03–1.23) | 1.24 (1.11–1.34) | |
Age, for a 10-year increase | 1.79 (1.75–1.83) | 1.83 (1.79–1.88) | 1.19 (1.14–1.25) |
Gender, male | 0.71 (0.68–0.74) | 0.70 (0.66–0.73) | 1.06 (0.94–1.20) |
Diabetes | 1.13 (1.07–1.20) | 1.10 (1.03–1.18) | 1.21 (1.02–1.44) |
Modified CCI (per unit) | 1.09 (1.08–1.11) | 1.06 (1.05–1.08) | 1.14 (1.10–1.18) |
Suboptimal starters | 1.11 (1.04–1.19) | 1.17 (1.07–1.26) | 0.90 (0.73–1.10) |
Underlying nephropathy | |||
Polycystic kidney disease | Reference | Reference | Reference |
Diabetes | 2.30 (1.93–2.74) | 2.16 (1.77–2.63) | 1.93 (1.26–2.96) |
Interstitial nephritis | 2.16 (1.79–2.61) | 2.04 (1.65–2.51) | 2.02 (1.28–3.18) |
Glomerulonephritis | 1.36 (1.13–1.63) | 1.26 (1.02–1.55) | 1.42 (0.92–2.18) |
Unknown | 2.18 (1.83–2.59) | 2.09 (1.72–2.54) | 1.73 (1.13–2.66) |
Uropathy | 1.84 (1.48–2.29) | 1.72 (1.34–2.21) | 1.79 (1.06–2.99) |
Vascular | 2.35 (1.99–2.78) | 2.22 (1.84–2.68) | 1.91 (1.27–2.87) |
Systemic disease | 1.87 (1.47–2.38) | 1.77 (1.35–2.33) | 1.72 (0.97–3.04) |
Other | 2.23 (1.68–2.95) | 2.06 (1.50–2.82) | 2.43 (1.18–5.01) |
Therapy before PD initiation | |||
No therapy | Reference | Reference | Reference |
HD | 1.14 (1.08–1.20) | 1.04 (0.97–1.12) | 1.32 (1.13–1.54) |
Transplantation | 0.54 (0.41–0.71) | 0.54 (0.39–0.74) | 0.67 (0.39–1.15) |
Type of centre | |||
Academic hospital | Reference | Reference | Reference |
Community hospital | 1 (0.95–1.07) | 1.03 (0.96–1.11) | 0.94 (0.79–1.11) |
Non-profit | 1 (0.93–1.07) | 0.98 (0.90–1.07) | 1.08 (0.90–1.30) |
Private hospital | 0.94 (0.87–1.02) | 0.94 (0.84–1.04) | 0.99 (0.77–1.28) |
Centre experience (new patients per year) | |||
≤10 | Reference | Reference | Reference |
>10 | 1.14 (1.09–1.20) | 1.17 (1.10–1.23) | 0.99 (0.87–1.13) |
According to the spline regression, PD start year was modelled as a linear variable (per year).
Association between PD start year and the PR of assisted PD initiation, adjusting for patient characteristics, for each type of assistance
Explanatory variable . | All assistance . | Nurse-assistance . | Family-assistance . |
---|---|---|---|
PR (95% CI) . | PR (95% CI) . | PR (95% CI) . | |
PD start year (reference = 2013) | PD start yeara | ||
2006 | 1.17 (1.07–1.29) | 1.08 (0.96–1.22) | 0.94 (0.92–0.97) a |
2007 | 1.27 (1.15–1.39) | 1.19 (1.05–1.34) | |
2008 | 1.24 (1.12–1.37) | 1.13 (0.99–1.27) | |
2009 | 1.21 (1.10–1.32) | 1.18 (1.05–1.33) | |
2010 | 1.14 (1.04–1.26) | 1.14 (1.02–1.28) | |
2011 | 1.09 (0.99–1.21) | 1.08 (0.96–1.21) | |
2012 | 1.16 (1.06–1.28) | 1.15 (1.03–1.27) | |
2013 | Reference | Reference | |
2014 | 1.08 (0.99–1.19) | 1.14 (1.02–1.29) | |
2015 | 1.12 (1.03–1.23) | 1.24 (1.11–1.34) | |
Age, for a 10-year increase | 1.79 (1.75–1.83) | 1.83 (1.79–1.88) | 1.19 (1.14–1.25) |
Gender, male | 0.71 (0.68–0.74) | 0.70 (0.66–0.73) | 1.06 (0.94–1.20) |
Diabetes | 1.13 (1.07–1.20) | 1.10 (1.03–1.18) | 1.21 (1.02–1.44) |
Modified CCI (per unit) | 1.09 (1.08–1.11) | 1.06 (1.05–1.08) | 1.14 (1.10–1.18) |
Suboptimal starters | 1.11 (1.04–1.19) | 1.17 (1.07–1.26) | 0.90 (0.73–1.10) |
Underlying nephropathy | |||
Polycystic kidney disease | Reference | Reference | Reference |
Diabetes | 2.30 (1.93–2.74) | 2.16 (1.77–2.63) | 1.93 (1.26–2.96) |
Interstitial nephritis | 2.16 (1.79–2.61) | 2.04 (1.65–2.51) | 2.02 (1.28–3.18) |
Glomerulonephritis | 1.36 (1.13–1.63) | 1.26 (1.02–1.55) | 1.42 (0.92–2.18) |
Unknown | 2.18 (1.83–2.59) | 2.09 (1.72–2.54) | 1.73 (1.13–2.66) |
Uropathy | 1.84 (1.48–2.29) | 1.72 (1.34–2.21) | 1.79 (1.06–2.99) |
Vascular | 2.35 (1.99–2.78) | 2.22 (1.84–2.68) | 1.91 (1.27–2.87) |
Systemic disease | 1.87 (1.47–2.38) | 1.77 (1.35–2.33) | 1.72 (0.97–3.04) |
Other | 2.23 (1.68–2.95) | 2.06 (1.50–2.82) | 2.43 (1.18–5.01) |
Therapy before PD initiation | |||
No therapy | Reference | Reference | Reference |
HD | 1.14 (1.08–1.20) | 1.04 (0.97–1.12) | 1.32 (1.13–1.54) |
Transplantation | 0.54 (0.41–0.71) | 0.54 (0.39–0.74) | 0.67 (0.39–1.15) |
Type of centre | |||
Academic hospital | Reference | Reference | Reference |
Community hospital | 1 (0.95–1.07) | 1.03 (0.96–1.11) | 0.94 (0.79–1.11) |
Non-profit | 1 (0.93–1.07) | 0.98 (0.90–1.07) | 1.08 (0.90–1.30) |
Private hospital | 0.94 (0.87–1.02) | 0.94 (0.84–1.04) | 0.99 (0.77–1.28) |
Centre experience (new patients per year) | |||
≤10 | Reference | Reference | Reference |
>10 | 1.14 (1.09–1.20) | 1.17 (1.10–1.23) | 0.99 (0.87–1.13) |
Explanatory variable . | All assistance . | Nurse-assistance . | Family-assistance . |
---|---|---|---|
PR (95% CI) . | PR (95% CI) . | PR (95% CI) . | |
PD start year (reference = 2013) | PD start yeara | ||
2006 | 1.17 (1.07–1.29) | 1.08 (0.96–1.22) | 0.94 (0.92–0.97) a |
2007 | 1.27 (1.15–1.39) | 1.19 (1.05–1.34) | |
2008 | 1.24 (1.12–1.37) | 1.13 (0.99–1.27) | |
2009 | 1.21 (1.10–1.32) | 1.18 (1.05–1.33) | |
2010 | 1.14 (1.04–1.26) | 1.14 (1.02–1.28) | |
2011 | 1.09 (0.99–1.21) | 1.08 (0.96–1.21) | |
2012 | 1.16 (1.06–1.28) | 1.15 (1.03–1.27) | |
2013 | Reference | Reference | |
2014 | 1.08 (0.99–1.19) | 1.14 (1.02–1.29) | |
2015 | 1.12 (1.03–1.23) | 1.24 (1.11–1.34) | |
Age, for a 10-year increase | 1.79 (1.75–1.83) | 1.83 (1.79–1.88) | 1.19 (1.14–1.25) |
Gender, male | 0.71 (0.68–0.74) | 0.70 (0.66–0.73) | 1.06 (0.94–1.20) |
Diabetes | 1.13 (1.07–1.20) | 1.10 (1.03–1.18) | 1.21 (1.02–1.44) |
Modified CCI (per unit) | 1.09 (1.08–1.11) | 1.06 (1.05–1.08) | 1.14 (1.10–1.18) |
Suboptimal starters | 1.11 (1.04–1.19) | 1.17 (1.07–1.26) | 0.90 (0.73–1.10) |
Underlying nephropathy | |||
Polycystic kidney disease | Reference | Reference | Reference |
Diabetes | 2.30 (1.93–2.74) | 2.16 (1.77–2.63) | 1.93 (1.26–2.96) |
Interstitial nephritis | 2.16 (1.79–2.61) | 2.04 (1.65–2.51) | 2.02 (1.28–3.18) |
Glomerulonephritis | 1.36 (1.13–1.63) | 1.26 (1.02–1.55) | 1.42 (0.92–2.18) |
Unknown | 2.18 (1.83–2.59) | 2.09 (1.72–2.54) | 1.73 (1.13–2.66) |
Uropathy | 1.84 (1.48–2.29) | 1.72 (1.34–2.21) | 1.79 (1.06–2.99) |
Vascular | 2.35 (1.99–2.78) | 2.22 (1.84–2.68) | 1.91 (1.27–2.87) |
Systemic disease | 1.87 (1.47–2.38) | 1.77 (1.35–2.33) | 1.72 (0.97–3.04) |
Other | 2.23 (1.68–2.95) | 2.06 (1.50–2.82) | 2.43 (1.18–5.01) |
Therapy before PD initiation | |||
No therapy | Reference | Reference | Reference |
HD | 1.14 (1.08–1.20) | 1.04 (0.97–1.12) | 1.32 (1.13–1.54) |
Transplantation | 0.54 (0.41–0.71) | 0.54 (0.39–0.74) | 0.67 (0.39–1.15) |
Type of centre | |||
Academic hospital | Reference | Reference | Reference |
Community hospital | 1 (0.95–1.07) | 1.03 (0.96–1.11) | 0.94 (0.79–1.11) |
Non-profit | 1 (0.93–1.07) | 0.98 (0.90–1.07) | 1.08 (0.90–1.30) |
Private hospital | 0.94 (0.87–1.02) | 0.94 (0.84–1.04) | 0.99 (0.77–1.28) |
Centre experience (new patients per year) | |||
≤10 | Reference | Reference | Reference |
>10 | 1.14 (1.09–1.20) | 1.17 (1.10–1.23) | 0.99 (0.87–1.13) |
According to the spline regression, PD start year was modelled as a linear variable (per year).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.